Thomas Chromecki
Impact in
Papers in
- Surgery 41
- Bladder and Urothelial Cancer Treatments 41
- Urinary and Genital Oncology Studies 14
-
- Renal cell carcinoma treatment 19
- Ferroptosis and cancer prognosis 3
- Co-authors
- Richard Zigeuner (38 shared papers)Georg C. Hutterer (28 shared papers)Peter Rehak (20 shared papers)Karl Pummer (22 shared papers)Cord Langner (19 shared papers)Shahrokh F. Shariat (24 shared papers)Martin Pichler (11 shared papers)Pierre I. Karakiewicz (16 shared papers)
- Journals
- The Journal of Urology (14 papers)British Journal of Urology (8 papers)World Journal of Urology (6 papers)Histopathology (4 papers)Journal of Clinical Oncology (3 papers)
- Partner nations
- AustriaUnited StatesCanada
In The Last Decade
Thomas Chromecki
58 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 82
- Surgery 973
- Urology 107
- Pulmonary and Respiratory Medicine 547
- Oncology 397
- Cancer Research 183
Countries citing papers authored by Thomas Chromecki
This map shows the geographic impact of Thomas Chromecki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Chromecki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Chromecki more than expected).
Fields of papers citing papers by Thomas Chromecki
This network shows the impact of papers produced by Thomas Chromecki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Chromecki. The network helps show where Thomas Chromecki may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Chromecki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 232 | |
| 2 | 2011 | 165 | |
| 3 | 2008 | 128 | |
| 4 | 2006 | 115 | |
| 5 | 2011 | 80 | |
| 6 | 2012 | 69 | |
| 7 | 2012 | 67 | |
| 8 | 2006 | 66 | |
| 9 | 2011 | 61 | |
| 10 | 2006 | 58 | |
| 11 | 2011 | 55 | |
| 12 | 2011 | 47 | |
| 13 | 2011 | 46 | |
| 14 | 2010 | 46 | |
| 15 | 2011 | 45 | |
| 16 | 2011 | 44 | |
| 17 | 2011 | 42 | |
| 18 | 2006 | 39 | |
| 19 | 2012 | 37 | |
| 20 | 2011 | 33 |
About Thomas Chromecki
Thomas Chromecki is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Oncology, Cancer Research and Epidemiology, having authored 62 papers that have together received 2.0k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (41 papers), Renal cell carcinoma treatment (19 papers), Urinary and Genital Oncology Studies (14 papers), Cancer Genomics and Diagnostics (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Multiple and Secondary Primary Cancers (3 papers), Inflammatory Biomarkers in Disease Prognosis (3 papers) and Ferroptosis and cancer prognosis (3 papers). The work is most often cited by research in Surgery (973 citations), Urology (107 citations), Pulmonary and Respiratory Medicine (547 citations), Oncology (397 citations) and Cancer Research (183 citations). Thomas Chromecki has collaborated with scholars based in Austria, United States and Canada. Frequent co-authors include Richard Zigeuner, Georg C. Hutterer, Peter Rehak, Karl Pummer, Cord Langner, Shahrokh F. Shariat, Martin Pichler, Pierre I. Karakiewicz, Karin Kampel‐Kettner and Douglas S. Scherr. Their work appears in journals such as The Journal of Urology, British Journal of Urology, World Journal of Urology, Histopathology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.